Global Pharma Corporation
Retail & Consumer Products · Lobbying Client
C
Influence Score
40/100
Moderate Influence
$1.2M
Total Lobby Spend
4
Policy Issues
1
Lobbyists
0
Revolving Door
Global Pharma Corporation reported $1.2 million in federal lobbying expenditures as disclosed in Senate LDA filings. The organization's lobbying activity spans 4 policy areas, with primary focus on Taxation, Labor/Workplace, Trade. This data is drawn from quarterly disclosure reports filed with the Secretary of the Senate under the Lobbying Disclosure Act of 1995.
Annual Lobbying Spend
Policy Issues
Government Entities Contacted
Dept of Labor
Dept of Agriculture
Dept of Homeland Security
US Trade Representative
US Senate
Securities & Exchange Commission
Dept of Commerce
Recent Filings
| Period | Registrant | Issues | Lobbyists | Amount |
|---|---|---|---|---|
| 2020 Jan-Mar | Covington & Burling LLP | TRDTAX | 1 | $50K |
| 2020 Apr-Jun | Cassidy & Associates LLP | LBRGOVTAX+1 | 1 | $42K |
| 2020 Jul-Sep | Brownstein Hyatt LLP | GOV | 1 | $74K |
| 2020 Oct-Dec | Akin Gump LLP | TRDLBRTAX+1 | 1 | $48K |
| 2021 Jan-Mar | K&L Gates LLP | LBRGOV | 1 | $52K |
| 2021 Apr-Jun | Cassidy & Associates LLP | TRDLBR | 1 | $70K |
| 2021 Jul-Sep | Squire Patton Boggs LLP | LBRTAX | 1 | $59K |
| 2021 Oct-Dec | Holland & Knight LLP | LBR | 1 | $68K |